Northland Securities Reduces Earnings Estimates for Transcat

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Securities reduced their Q3 2027 earnings estimates for Transcat in a research note issued to investors on Wednesday, August 5th. Northland Securities analyst T. Jackson now forecasts that the scientific and technical instruments company will earn $0.20 per share for the quarter, down from their previous forecast of $0.38. Northland Securities currently has a “Market Perform” rating and a $95.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.63 per share. Northland Securities also issued estimates for Transcat’s FY2028 earnings at $2.12 EPS, FY2029 earnings at $2.58 EPS and FY2030 earnings at $3.01 EPS.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Transcat had a net margin of 0.99% and a return on equity of 5.56%. The company had revenue of $92.95 million during the quarter, compared to the consensus estimate of $86.55 million.

TRNS has been the subject of a number of other research reports. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings upgraded Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. Finally, Wall Street Zen raised Transcat from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $105.50.

Transcat Trading Up 0.8%

TRNS opened at $94.54 on Friday. The stock has a market capitalization of $884.89 million, a P/E ratio of 255.51 and a beta of 0.68. The company has a current ratio of 2.49, a quick ratio of 1.99 and a debt-to-equity ratio of 0.36. Transcat has a 12 month low of $50.23 and a 12 month high of $95.22. The firm’s fifty day simple moving average is $89.42 and its 200 day simple moving average is $79.52.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in TRNS. Lazard Asset Management LLC acquired a new stake in Transcat in the 2nd quarter valued at $54,000. Tower Research Capital LLC TRC boosted its stake in shares of Transcat by 245.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after buying an additional 798 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of Transcat during the 4th quarter worth about $236,000. Balyasny Asset Management L.P. bought a new position in shares of Transcat in the 4th quarter valued at about $247,000. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Transcat by 8.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock valued at $299,000 after acquiring an additional 432 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Trending Headlines about Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s latest quarterly results exceeded expectations, with earnings of $0.51 per share versus the $0.38 consensus and revenue of $92.95 million versus $86.55 million expected. The Service segment remains the primary growth driver, and management is targeting high-single-digit organic Service growth as it expands its operational-excellence initiatives. Transcat’s Q2 CY2026: Strong sales
• Positive Sentiment: Shares remain above both their 50-day and 200-day moving averages, reflecting strong recent momentum following the earnings beat and improving demand for calibration and technical services.
• Neutral Sentiment: Northland Securities maintains a “Market Perform” rating and a $95 price target, which is close to the stock’s recent trading level. This suggests the firm sees limited near-term valuation upside despite the company’s longer-term growth opportunities. Northland Securities rating information
• Negative Sentiment: Northland downgraded Transcat from “Outperform” to “Market Perform,” citing a less favorable risk-reward profile after the stock’s advance. The $95 target implies only modest upside from the referenced trading level.
• Negative Sentiment: Northland reduced its EPS forecasts across the outlook: Q2 2027 to $0.41 from $0.45, Q4 2027 to $0.60 from $0.62, FY2027 to $1.71 from $1.86, and FY2031 to $3.53 from $3.88. The revisions indicate concern about growth or profitability, while recent coverage also highlights persistent margin pressure. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.